Skip to main content
HR 6897 118th Congress House Health

Synthetic Biology and Active Pharmaceutical Ingredients Act

Introduced: December 22, 2023 Introduced by: Slotkin, Elissa Democratic · Michigan See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 22, 2023
Referred to the House Committee on Armed Services.
Dec 22, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Synthetic Biology and Active Pharmaceutical Ingredients Act

This bill requires the Department of Defense (DOD) to establish a pilot program to support domestic manufacturing of critical pharmaceutical ingredients and their components through certain novel technology.

Specifically, DOD must establish a three-year program that uses technology involving synthetic biology to support domestic manufacturing of pharmaceutical ingredients and related incorporated materials that (1) are not available in a sufficient quantity or quality domestically, and (2) are strategically important to the United States.

 

What's happening now December 22, 2023

Referred to the House Committee on Armed Services.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6897: Synthetic Biology and Active Pharmaceutical Ingredients Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-6897/
MLA
"H.R. 6897: Synthetic Biology and Active Pharmaceutical Ingredients Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-6897/.
Bluebook (legal)
H.R. 6897, 118th Cong. (2026), https://openamerica.io/bill/118-HR-6897/.
Markdown link
[H.R. 6897: Synthetic Biology and Active Pharmaceutical Ingredients Act](https://openamerica.io/bill/118-HR-6897/)
Report a problem